title: Obesity-hypertension: the effects on cardiovascular and renal systems.
abstract: Longitudinal and cross-sectional studies suggest that a large number of obese patients have a high prevalence of hypertension. This association causes the following changes: insulin and leptin resistance with a suppressed biologic activity of natriuretic peptide, which contributes to sodium retention with concomitant expanded cardiopulmonary volume and increased cardiac output. The cellular metabolism of cations may be altered in obesity and may lead to changes in vascular responsiveness and increased vascular resistance. These changes lead to structural adaptations in the heart characterized by concentric-eccentric left ventricular hypertrophy. The hypertrophic condition provides the basis for the development of congestive heart failure and cardiac arrhythmias that may explain the higher rates of cardiac sudden death in those patients. In the kidneys, obesity hypertension may initiate a derangement of renal function. The increased deposit of interstitial cells and of extracellular matrix between the tubules induces higher interstitial hydrostatic pressure and tubular sodium reabsorption. The consequent increase in renal flow and glomerular filtration enhances albuminuria excretion and the susceptibility to the development of renal damage. In summary, the hemodynamic and structural adaptations related to obesity hypertension is the cause of greater risk for adverse cardiovascular and renal events.
authors.affiliation: Louisiana State University Center Health Science Center, New Orleans, USA.
authors.forename: R
authors.initials: R
authors.lastname: Zhang
authors.forename: E
authors.initials: E
authors.lastname: Reisin
mesh_terms: D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology*; D007668:Kidney / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D020738:Leptin / Q000494:pharmacology / Q000502:physiology; D045283:Natriuretic Agents / Q000502:physiology; D009765:Obesity / Q000150:complications* / Q000473:pathology / Q000503:physiopathology*
chemical_list: D020738:Leptin; D045283:Natriuretic Agents